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ABSTRACT The D-Ala-D-Ala carboxypeptidases/
transpeptidases (penicillin-binding proteins, PBPs) share con-
siderable structural homology with class A P-1actamases (EC
3.5.2.6), although these j3-lactamases have no observable D-
Ala-D-Ala carboxypeptidase activity. With the objective of
recruiting such activity into a 3-lactms background, we
have prepared a chimeric protein by inserting a 28-amino acid
segment of PBP-5 of Escherichia cofi in place of the corre-
sponding region ofthe RTEM-1 /8-la . The segment thus
inserted encompasses two residues conserved in both families:
Ser-70, which forms the acyl-enzyme intermediate during
(-lactam hydrolysis, and Lys-73, whose presence has been
shown to be necessary for catalysis. This chimera involves
changes of 18 residues and gives a protein that differs at 7% of
the residues from the parent. Whereas RTEM -lactamas has
no D-Ala-D-Ala carboxypeptidase activity, that of the chimera
is significant and is, in fact, about 1% the activity of PBP-5 on
diacetyl-L-Lys-D-Ala-D-Ala; in terms of free energy of activa-
tion, the chimera stabilizes the transition state for the reaction
to within about 2.7 kcal/mol of the stabilization achieved by
PBP-5. Furthermore, the chimera catalyzes hydrolysis exclu-
sively at the carboxyl-terminal amide bond which is the site of
cleavage by D-Ala-D-Ala carboxypeptidase. Though containing
all those residues that are conserved throughout class A
(3-lactamases and are thought to be essential for I3-lactamase
activity, the chimera has considerably reduced activity (=10-3)
on penams such as penicillins and ampicillins as substrates. As
a catalyst, the chimera shows an induction period of =30 mm,
reflecting a slow conformational rearrangement from an inac-
tive precursor to the active enzyme.
The many examples of class A 13-lactamases (EC 3.5.2.6)
show striking similarities to a large group of enzymes,
collectively known as penicillin-binding proteins (PBPs), that
are involved in the cross-linking of the peptidoglycan in the
final stage of the synthesis of the bacterial cell wall (1-3). In
catalyzing the cleavage of a D-Ala-D-Ala peptide bond at the
carboxyl terminus of one polypeptide chain and transferring
the amino-terminal remainder to the amino terminus of
another polypeptide in a transpeptidase reaction, these en-
zymes play an essential role in cross-linking the bacterial cell
wall, thereby stabilizing the cells against rupture in hypotonic
environments (4). The enzymes can also act as D-Ala-D-Ala
carboxypeptidases (D,D-carboxypeptidases) by simple hy-
drolysis of the carboxyl-terminal D-Ala-D-Ala peptide bond.
The 83-lactam substrates of the /B-lactamases are close
structural homologues of the D-Ala-D-Ala dipeptide. This led
to the proposal of an evolutionary relationship between the
,8-lactamases and the PBPs (5). This relationship is further
strengthened by similarities in several stretches ofamino acid
sequence, particularly among amino acid residues that are
now known to lie within the active site region (6). Moreover,
the general foldings ofthe polypeptide chains in 3-lactamases
and one PBP (the R61 carboxypeptidase of Streptomyces)
show considerable conservation of secondary structural fea-
tures (3). However, f3-lactamases do not catalyze the hydrol-
ysis of peptide bonds in noncyclic PBP substrates (though
they can catalyze the hydrolysis of open chain esters), and
PBPs do not effectively catalyze the hydrolysis of 3-lactam
antibiotics though they can form relatively stable acyl en-
zyme intermediates with lactams; indeed, the formation of
these intermediates is the likely pathway of irreversible
inhibition by which 83-lactams are thought to manifest their
action as antibiotics (1, 2, 4).
Can one recruit carboxypeptidase activity into a 1-
lactamase by replacing structural elements of a 84-lactamase
with homologous elements of a PBP? To explore this possi-
bility and, more generally, the ways in which one might
change the scope of an enzyme's catalytic activity, we have
constructed a chimera of the RTEM-1 .3-lactamase and the
Escherichia coli PBP-5 carboxypeptidase. We chose PBP-5
of E. coli because it and the RTEM P-lactamase have the
greatest sequence similarity (27%) in the active site (6).
Moreover, most carboxypeptidases slowly degrade the pen-
icilloyl group into phenylacetylglycine, whereas PBP-5 cat-
alyzes hydrolysis to form penicilloic acid at a significantly
higher rate than most PBPs, suggesting a closer evolutionary
relationship to /3-lactamases (7). In targeting the residues for
replacement we were guided by sequence homologies rather
than three-dimensional structural considerations because, at
the time, no appropriate high-resolution structures were
available.
Site-directed mutagenesis has previously been used, for
example, to generate mutants with altered sequence recog-
nition forDNA binding and substrate specificity in enzymatic
catalysis and to create interspecies hybrids. By substituting
five amino acids in the "outside" surface of the DNA
recognition a-helix ofthe 434 repressor, with the correspond-
ing amino acids from the P22 repressor, a chimera was
produced with P22 DNA recognition in a 434 background (8).
Replacement of the nonpolar substrate binding domain of
ornithine transcarbamoylase with the analogous nonpolar
domain of aspartate transcarbamoylase generated an active
chimera that has aspartate transcarbamoylase activity,
though at a level considerably lower than that of the native
enzyme (9). For phosphoglycerate kinase, two interspecies
chimeras were constructed, each composed of one domain
from the human enzyme and one domain from the yeast
enzyme. Despite a 35% difference in the amino acid compo-
sition between human and yeast phosphoglycerate kinases,
Abbreviations: PBP, penicillin-binding protein; D,D-carboxypepti-
dase, D-Ala-D-Ala carboxypeptidase; Lac, lactate.
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the catalytic properties of the chimeras were very similar to
those of the parental enzymes (10).
MATERIALS AND METHODS
Materials. All enzymes were purchased from Boehringer
Mannheim. Antibiotics, peptide substrates, and 2-mercapto-
ethanol were from Sigma. Radioactive materials were sup-
plied by Amersham. Isopropyl f-D-thiogalactoside (IPTG)
was purchased from IBI. Molecular biology grade reagents
agarose, phenol, and chloroform were also from IBI. o-
Phthaldialdehyde and sodium tetraborate were from Fluka.
E. coli was used in all experiments. Plasmid pBR322 DNA
was harbored in strain HB101; the pJN (11) expression vector
was propagated in strain D1210, which is lacIq. Bacterio-
phage were propagated in strain JM101. The culture medium
was L broth unless otherwise indicated. Cells were made
competent for transformation of plasmid DNA by using a
process adapted from Hanahan (12).
Oligonucleotides were synthesized by using phosphor-
amidite chemistry (13) on the Applied Biosystems automated
DNA synthesizer, model 380A. They were then purified by
preparative polyacrylamide gel electrophoresis.
Wild-type plasmid pBR322 and bacteriophage M13mpl8
replicative form (RF) DNA were purchased from Bethesda
Research Laboratories. Mutant plasmids and RF phage DNA
were purified from E. coli by the alkaline lysis method (14).
Large-scale preparations were further purified by ultracen-
trifugation in cesium chloride/ethidium bromide gradients.
Construction of the RTEM-PBP-5 Chimera. The EcoRI/Pst
I [752 base pairs (bp)] fragment containing part of the
8-lactamase gene of pBR322-DC9 (15), a mutant containing a
silent mutation creating a Nar I site at nucleotide 3924, was
subcloned in M13mp8 for the cassette mutagenesis with the
synthetic cassette corresponding to the PBP-5 sequence (Fig.
1). The replicative form DNA of the resulting M13 derivative
was digested with Xho I/Ban II, and the resulting 1-kbp
fragment was isolated. A second digestion of the M13 deriv-
ative was performed with Nar I/Ban II and the resulting
7-kbp fragment was isolated. Synthetic oligonucleotides were
annealed by heating 50 pmol of each to 95°C in 100 ,ul of 10
mM TrisHCI, pH 7.5/10 mM MgCI2/50 mM NaCl and
allowing the solution to cool to room temperature over 2 hr.
Annealed oligonucleotides (0.4 pmol) were combined with
approximately 0.04 pmol of vector [Xho II/Ban I fragment (1
kbp); Nar I/Ban 11 (7 kbp)] to give a 10:1 molar ratio of insert
to vector. This was incubated in 10 mM Tris HCI, pH 8.0/5
mM MgCl2/5 mM dithiothreitol/1 mM ATP containing 2
units ofT4 DNA ligase in a total volume of 25 1l for 12-14 hr
at 16°C; 10 ,ul of the reaction mixture was used to transform
competent E. coli JM101; the resulting cells were plated on
2x YT medium (16 g of Bactotryptone, 10 g of yeast extract,
and 5 g ofNaCl per liter). The three-piece ligation yielded the
desired chimera as verified by sequencing. The mutant was
then subcloned back into pBR322.
Plasmid DNA was sequenced by using a modification of
the Sanger dideoxy method (16) for denatured, double-
stranded DNA (17). Plasmid DNA was suspended in TE (10
mM TrisHCl, pH 8.0/1 mM EDTA) with 100 pmol of
sequencing primer in a volume of 10 ,ul. The mixture was
incubated at 95°C for 4 min, then snap frozen in a dry
ice/ethanol bath. Chain extension reactions were performed
with a Sequenase kit from United States Biochemical (18).
Labeling was accomplished with deoxyadenosine 5'-[a-[35S]-
thio]triphosphate.
Protein Purification and Analysis. Western blots (Fig. 2)
were prepared to examine stability in vivo. Colonies harbor-
ing mutants were grown to late logarithmic phase (ODse
1.0); a 1.5-ml sample of each was pelleted by centrifugation
and resuspended in 100 A.l of protein sample buffer [10%o
(vol/vol) glycerol/5% (vol/vol) 2-mercaptoethanol/3% (wt/
vol) SDS/62.5 mM Tris HCl, pH 6.8/1.0 mM EDTA/0.05%
bromophenol blue] and heated to 950C for 10 min to lyse the
cells. Aliquots (20 ul) were loaded onto a 15-cm, 12%
polyacrylamide stacking gel and run at a constant current of
5 mA for 12-16 hr. Protein was then transferred from the gel
onto DEAE-nitrocellulose by using a Bio-Rad Transblot cell
for 2 hr at 100 mA. 13-Lactamase was visualized following
binding of rabbit anti-p-lactamase (19) by using the highly
sensitive Vectastain ABC immunoperoxidase system (20).
Mutant genes were subcloned in pJN (11), an expression
vector utilizing the tac promoter (21), for the overproduction
of P-lactamase. Cells were grown in XB medium (25 g of
Bactotryptone, 7.5 g of yeast extract, and 50 ml of 1 M Tris
HCI, pH 7.5, per liter) at 30'C until they reached stationary
phase. Isopropyl f3-D-thiogalatoside (0.1 M) was added and
the culture was cooled to 0C. After 30 min the cells were
harvested and the crude protein was collected by osmotic
extrusion (22). The chimera was then purified by anion-
exchange (Whatman DE-52 DEAE-cellulose) followed by gel
filtration (Sephadex G-100). Purity was checked by electro-
phoresis in SDS/12% polyacrylamide gels stained with
Coomassie blue. The protein concentration was estimated by
A281 using the extinction coefficient 29,400 M-1-cm-1 (22).
During purification of the chimera ampicillin was included in
all buffers at 40 mg/liter.
Kinetic analyses of ,B-lactamase activities were performed
at 30°C in 0.1M potassium phosphate, pH 7.0. The hydrolysis
of the lactam bond was monitored at 232 nm to obtain initial
velocities. Ae = 500 M-1cm-1 for benzylpenicillin (23).
D,D-Carboxypeptidase activities were determined at 37°C in
0.1 M Tris HCI, pH 7.5. A fluorescence assay (24, 25) was
employed to measure the carboxypeptidase activity, with
Na,NE-diacetyl (diAc)-L-Lys-D-Ala-D-Ala as a substrate. Re-
actions (in 0.25 ml) were initiated at several substrate con-
centrations. Aliquots (50 ul) were collected at intervals of 30
min and added to 2 ml of buffered reagent [1.5 ml of
o-phthaldialdehyde solution (5 mg/ml of ethanol), 1.5 ml of
2-mercaptoethanol solution (5 ,ul/ml of ethanol), and 90 ml of
aqueous 0.05 M sodium tetraborate, pH 9.5]. The samples
were read within 15 min of mixing on an SLM 4800 fluores-
cence spectrophotometer (SLM AMINCO, Urbana, IL).
Excitation and emission monochromators were set at 340 nm
and 455 nm, respectively, with a 2-nm slit width. The flu-
orescence value was corrected against the time-zero value and
the concentration of D-alanine was determined from a calibra-
tion curve. To obtain the activity vs. pH plot, reactions were
performed at 0.02 M diAc-L-Lys-D-Ala-D-Ala while varying
pH and buffer systems: 0.1 M KOAc, pH 5.0 and 6.0; 0.1 M
Tris HCl, pH 7.0,7.5,8.0,8.5, and 9.0; 0.1 M KH2PO4, pH 7.0
and 8.0; and 0.1 M K2CO3, pH 8.5 and 9.0. To assay the
hydrolysis of the depsipeptide diAc-L-Lys-D-Ala-D-Lac (Lac
= lactate), parallel reactions were initiated at a single substrate
concentration. Reactions were quenched at timed intervals by
snap-freezing in dry ice/ethanol. The remaining quantity of
depsipeptide starting material in the samples was determined
by isolation on reverse-phase HPLC using a linear gradient of
acetonitrile/water (0.1% trifluoroacetic acid) and the protein
content was quantified by A214. A blank run (starting material
only) was performed for calibration. Radiolabeled (3H) sub-
strate was used to detect activity for the lower-activity chi-
mera. The products were separated by paper chromatography
(26). To assay the chimeras for transpeptidase activity, dep-
sipeptide digestions (in 0.1 M Tris HCI, pH 7.5, 37°C) were
initiated with glycine present in the reaction mixture. The
reaction was quenched at 3 hr and the mixture was analyzed
for the formation of the tripeptide diAc-L-Lys-D-Ala-Gly by
HPLC.
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RESULTS AND DISCUSSION
To construct the chimeric enzyme, we replaced a 28-amino
acid sequence encompassing the active site region in RTEM-
1 ,8-lactamase [residues 50-77 in the Ambler convention (27)]
with a corresponding sequence from PBP-5 (residues 24-51
in the PBP convention, which does not include residues for
any leader sequence) (Fig. 1). The gene encoding the chi-
meric protein was assembled in a three-piece ligation utilizing
RTEM-1 8-lactamase encoded by plasmid pBR322 and a
synthetic duplex encoding the PBP-5 insert. The resulting
structural gene was subcloned in pJN (11), an expression
vector that utilizes the tac promoter (21) and allows the
overexpression even of inactive mutants of .-lactamase by
encoding a gene for kanamycin resistance as a selectable
marker.
E. coli strain D1210 cells containing the plasmid encoding
the chimera do not show a resistant phenotype to penam
antibiotics such as penicillins and ampicillins above the level
conferred by a chromosomally encoded 83-lactamase (6-10
,ug/ml). Nevertheless, the chimeric protein can be isolated
from the periplasm of such cells (grown in the presence of
kanamycin at 50 /Lg/ml) by osmotic extrusion (22). The crude
protein was then purified by anion-exchange followed by
gel-filtration chromatography. Purity was confirmed by anal-
ysis on SDS/12% polyacrylamide gels. Protein concentration
for kinetic analyses was estimated by A281 using the 3-
lactamase extinction coefficient 29,400 M-l cm-1 (22).
Preliminary assessment of the activity of the purified
chimera toward benzylpenicillin (300C, pH 7) revealed an
induction period of about 30 min. After a particular reaction
was allowed to proceed to complete conversion, newly added
substrate was hydrolyzed without such an induction period.
Also, whereas incubation of the chimeric protein at 37°C for
4 hr resulted in complete loss of activity, the chimera, when
similarly incubated in the presence ofampicillin, retained full
activity. These observations suggested that the initially in-
active chimeric protein undergoes a slow conformational
change to an active enzyme upon binding substrate. More-
over, they suggested that the presence of a f3-lactam may
stabilize a properly folded conformation of the chimera and
thereby discourage its proteolytic degradation in the peri-
plasm. To examine the latter possibility, cells were grown in
the presence of sublethal concentrations (6 ,ug/ml) of ampi-
cillin (and the normal concentrations of kanamycin); cells
grown under these conditions contain about twice as much
chimeric protein as those grown in the absence of 8-lactam
antibiotic (Fig. 2). Subsequent purifications of the chimera
were performed with excess ampicillin (40 ,ug/ml) in all
buffers.
Table 1 collects representative kinetic parameters for the
chimeric enzyme acting both as af,-lactamase and as a
D-Ala-D-Ala carboxypeptidase. These parameters for both
,8-lactamase and carboxypeptidase activities were deter-
mined for chimera that had been equilibrated with ampicillin
to assist folding of the protein into the active conformation.
(In the absence of either penam antibiotics or diAc-L-Lys-
D-Ala-D-Ala substrate for periods in excess of about 30 min,




FIG. 2. Western blots of wild-type and chimeric enzymes. Lane
A shows the amount ofchimera present when cells were grown in the
presence of sublethal levels of ampicillin; lane B shows the amount
of chimera present at 37°C; and lane C shows the expression of
wild-type f-lactamase at 37°C. Note that the increase in the intensity
of the chimera band in the presence of ampicillin reflects the
stabilizing effect of the antibiotic on the chimera.
ypeptidase decay.) With benzylpenicillin as substrate, the
turnover rate is sharply reduced relative to that for the
RTEM-1-f3-lactamase (-10-5) (19) and somewhat increased
relative to that for PBP-5 (=102) (28). Activity of the chimera
as a D,D-carboxypeptidase was assessed by using as sub-
strate diAc-L-Lys-D-Ala-D-Ala (26) and the depsipeptide
analogue diAc-L-Lys-D-Ala-D-Lac (31). Whereas RTEM /-
lactamase does not measurably catalyze the hydrolysis of
either substrate, the chimeric enzyme has considerable such
activity and shows about 1% the activity of PBP-5 (kcat/Km)
toward the acylated tripeptide and 0.4% toward the acylated
depsipeptide. In terms of free energies of activation, this
places the stabilization by the chimera of the transition state
for hydrolysis of D-Ala-D-Ala dipeptides within about 2.7
kcal/mol, and for hydrolysis of the depsipeptide within 3.3
kcal/mol, of that achieved by PBP-5 itself (1 kcal = 4.18 kJ).
In both cases, hydrolysis occurs exclusively at the carboxyl-
terminal peptide bond between the two D-Ala residues and at
the terminal ester bond at which PBP-5 itself cleaves. The
rate of nonenzymatic hydrolysis of a peptide bond in aqueous
solution at neutral pH is on the order of 3 x 10-9 sec-1 (32),
thus the rate ofthe reaction catalyzed by the chimera is about
109 that for uncatalyzed amide hydrolysis at pH 7.
In the course of this work, we also recovered a second
chimera (E+) that contains an extra glutamic residue between
residues 59 and 60 [/-lactamase numbering (27)]. This chi-
mera exhibited a kcat for D,D-carboxypeptidase activity two
orders of magnitude less and a f3-lactamase activity toward
benzylpenicillin about an order ofmagnitude greater than that
ofthe chimera without this additional residue (Table 1). Also,
in the chimera with the glutamic residue insertion (E+) we
observe an induction period during the hydrolysis ofj3-lactam
antibiotics. We conclude that the additional residue must be
accommodated by the flexibility of the random coil segment
and, while it does hinder the carboxypeptidase activity, the
augmented chimera (E+) favors 83-lactam hydrolysis com-
pared to the chimera without the insertion.
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FIG. 1. Line A, the amino acid sequence of residues 50-77 of RTEM-1 ,-lactamase (22); line B, the corresponding amino acid sequence of
PBP-5 (6); and line C, the sequence of the resulting chimera. Standard one-letter symbols are used and the active serine is outlined. Conserved
residues are capitalized and exchanged residues in the chimera are boldface.
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Table 1. Kinetic parameters for wild-type PBP-5 from E. coli, wild-type RTEM-1 P-lactamase, and the RTEM/PBP-5 chimeric enzyme
diAc-L-LyS-D-Ala-D-Ala* diAc-L-LyS-D-Ala-D-Lac* Benzylpenicillint
Km, kcat, kcat/Km, Km, kcat, kcat/Km, Km, kcat, kcat/Km,
Enzyme mM sec1 M-l sec1 mM sec-1 M-1lsec1 mM sec-1 M'-1sec1
PBP-5t 19.2 0.29 15 2.4 1.1 260 ND 10-4-10-3 ND
RTEM-1§ - 0.02 2 x 103 1 x 108
Chimeras 7.7 ± 1.3 0.0012 ± 0.00017 0.16 3.3 ± 1 0.0037 ± 0.0015 1.1 0.26 ± 0.03 0.051 ± 0.005 1%
Chimera (E')II ND 5.8 x 10-5 ND ND ND ND ND 1.3 ND
ND, not determined.
*Assay conditions: 370C, pH 7.5.
tAssay conditions: 300C, pH 7.0.
tKinetic parameters for PBP-5 were taken from ref. 28. Activity with benzylpenicillin is an estimate based on comparisons between PBPs
involving the rates of deacylation (29, 30).
§The lack of observable activity is designated as
lKinetic parameters were calculated from initial velocities; ± indicates SD.
Specific activities determined from single reaction curves; E+, extra glutamic residue.
Both chimeras exhibit a pH profile for carboxypeptidase
activity similar to that we observe for the parent RTEM
f3-lactamase (33) on penam substrates and, as shown in Fig.
3, very different from that of the PBP-5 wild-type enzyme.
Notable also is the fact that both chimeras show no buffer
dependency, whereas PBP-5 itself shows a marked decrease
in activity in carbonate and phosphate buffers.
We have also prepared a number of mutants with more
moderate PBP-5 substitutions (i.e., Thr-71-->Leu; Thr-
71-+Leu; Phe-72-->Thr; Thr-71-dle; Thr-71--Ile, Phe-
72--Thr; and Phe-72-+Thr) to examine the effect of gener-
ating the conserved triad Ser-Xaa-Thr-Lys present in all
membrane-bound D,D-carboxypeptidases (6). These mutants
were generally unstable and none showed any D,D-
carboxypeptidase activity; indeed at 370C the Thr-71--+Leu
mutant conferred only a modest resistance to 8-lactam anti-
biotics (35) because of the susceptibility of this mutant to
proteases in the periplasm. The other mutants with PBP-
5-like sequences exhibited low to moderate f3-lactamase
activities (Table 2). These mutations likely interfere with the
normal folding of the a-2 helix of P-lactamase (35, 36), as the
side chain of Thr-71 points into the hydrophobic core of the
enzyme. A similar effect has been observed in the case of
substitutions of Thr-157 in phage T4 lysozyme (37).
In addition to having carboxypeptidase activity, PBPs
generally function as transpeptidases, in which role they can
transfer the carboxyl group of the cleaved amide to an amine
such as glycine (4, 34). Our chimeras do not display any such
activity; no transpeptidase transfer to glycine was observed
even at 100 mM glycine. This lack of transpeptidase activity
may reflect the absence in the j3-lactamase/PBP-5 chimera
(29 kDa) of helix G (3), which is likely to be present in PBP-5
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R61 carboxypeptidase and therefore inferred in the closely
homologous PBP-5, covers the face of the binding site for
,3-lactam substrate and may contain a structural component,
such as an amino acid or peptide binding site, necessary for
transpeptidase activity. This helix may also help to exclude
water from the active site, thereby encouraging transpepti-
dase as distinct from carboxypeptidase activity.
The evidence that the D,D-carboxypeptidase activities
reported in this paper truly reside in the chimeras and do not
derive from contamination with PBP-5 includes the following
observations. (i) Proteins purified by the procedures for
isolating ,3-lactamase and its mutants from E. coli containing
derivatives of pBR322 have observable D,D-carboxypepti-
dase activity only when the two specific chimeras that form
the subject of this paper are encoded in the plasmids. (ii) The
two chimeras have markedly different levels of activities
from each other, and both have pH dependencies very
different from those reported for PBP-5. (iii) Neither chimera
catalyzes a transpeptidase reaction with glycine, whereas
PBP-5 does.
CONCLUSIONS
We do not know precisely the particular residues in the
chimera responsible for the altered catalysis and whether
catalysis results from changes in a few particular interactions
between enzyme and potential substrate or from larger, more
general conformational alterations. We are trying both to
narrow the changes necessary to achieve carboxypeptidase
activity (the chimera has substitutions at 7% of the residues
of the parent enzyme) and to create variants of this chimera
with increased activity as a carboxypeptidase and eventually
as a transpeptidase. Accordingly, the results of this work to
pH
FIG. 3. pH dependency of the D,D-carboxypeptidase activity of RTEM/PBP-5 chimeras and of E. coli PBP-5. (a) RTEM/PBP-5 chimera.
(b) E+ chimera, which contains an additional glutamic residue inserted between residues 59 and 60 in P-lactamase numbering (see Fig. 1). (c)
Wild-type PBP-5 (plot taken from ref. 34). *, KOAc; O, KH2PO4; *, Tris-HCI; n, K2CO3.
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Table 2. Catalytic parameters for Thr-71 and Phe-72 mutants of
RTEM-1 3-lactamase
Ampicillin
Km, kcat, kcat/Km, Relative
Enzyme uM sec' M-l sect kcat/Km
Thr-71, Phe-72 (wild-type) 50 2000 4.0 x 107 1
Thr-71--Ile 50 145 2.9 x 106 7.2 x 10-2
Thr-71--+Ile, Phe-72-*Thr 80 3.6 4.5 x 104 1.1 x 10-3
Phe-72-*Thr 16 338 2.1 x 107 5.2 x 10-1
Kinetic parameters were determined from initial velocities at 300C
and pH 7.0.
date can be regarded as a significant first step toward the goal
of designing proteins with altered and potentially novel
catalytic activities.
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